Sun Pharmaceutical and Almirall which is a Spanish firm have entered into a licencing agreement for development and commercialisation of tildrakizumab which is used to...
A licensing arrangement has been entered between Sun Pharma Advanced Research Company (SPARC) and its parent Sun Pharma for its Elepsia tablets that are used...